CompoAtlas

Duo 24 Cheveux Femmes 45+

Food supplement declared in France, decision dated 13 February 2025

Duo 24 Cheveux Femmes 45+ (VITAVEA - Laboratoires Yves Ponroy) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Eruca vesicaria 100 mg per day, Carthamus tinctorius 50 mg per day, Bambusa bambos 40 mg per day, Urtica dioica 40 mg per day, Urtica dioica 34 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
VITAVEA - Laboratoires Yves Ponroy
Food business operator placing the product on the market
HAVEA COMMERCIAL SERVICES
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
1 gélule jour et 1 gélule nuit
Directions for use
Avaler une gélule jour avec un verre d'eau le matin. Avaler une gélule nuit avec un verre d'eau le soir.
Intended populations
Women
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Kidney failure, Infants (under 1 year), Heart problems, Taking diabetes medication, Prolonged use, Children (under 6), Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Hair and nails

Declaration 7587, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Eruca vesicaria L. Cav.Parties aériennesExtrait sec hydroalcoolique100 mg
Carthamus tinctorius L.Graine (huile)Pression à froid50 mg
Bambusa bambos (L.) VossExsudatExtrait sec aqueux40 mg
Urtica dioica L.FeuilleExtrait sec aqueux40 mg
Urtica dioica L.FeuilleExtrait sec aqueux34 mg
Bambusa bambos (L.) VossExsudatExtrait sec aqueux34 mg
Adiantum capillus-veneris L.Parties aériennesExtrait sec hydroalcoolique20 mg
Vaccinium myrtillus L.BaieExtrait sec hydroalcoolique20 mg

Other active ingredients

NamePer day
Hydrolysat de kératinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothenate, calciumPantothenic acid (vitamin B5)no limit (insufficient data)dose annulled by the French Council of State in 2011
D-biotinBiotin (vitamin B8)no limit (insufficient data)dose annulled by the French Council of State in 2011
copper bisglycinateCopper5,000 µg2,000 µg
riboflavinVitamin B2 (riboflavin)no limit (insufficient data)dose annulled by the French Council of State in 2011
pyridoxine hydrochlorideVitamin B612 mg2 mg
zinc oxideZinc25 mg15 mg

Additives

E530, E170, E470b, E460

Other ingredients

Pisum sativum L., Gélule végétale

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Ne pas utiliser en cas de grossesse ou d'allaitement. Déconseillé chez les personnes sous traitement antidiabétique. Ne pas dépasser la dose journalière recommandée. A garder hors de portée des enfants. A conserver dans un endroit sec et frais à l'abri de la chaleur et de la lumière. A consommer dans le cadre d'une alimentation variée et équilibrée et d'un mode de vie sain. La consommation doit être limitée à quelques semaines/mois. Déconseillé aux enfants de moins de 12 ans. Déconseillé en cas d'insuffisances cardiaque ou rénale œdémateuses.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Urtica dioica L.
    Read the warning, when it applies and the studies cited

    STINGING NETTLE JUICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except nutritive tonics.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Tilgner 1999).

    Sources cited by Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Tilgner S. Herbal Medicine from the Heart of the Earth. Creswell (OR): Wise Acre Press; 1999.

    Known adverse reactions

    Condition of application: All products except those making only a diuretic claim*.

    When using this product diuretic effect may occur.

    *Note: This statement can be removed from the label if a diuretic claim is included.

    Health Canada monograph dated 27 March 2026

    STINGING NETTLE - URTICA DIOICA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except nutritive tonics.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Tilgner 1999).

    Sources cited by Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Tilgner S. Herbal Medicine from the Heart of the Earth. Creswell (OR): Wise Acre Press; 1999.

    Known adverse reactions

    All products except those making only a diuretic claim*

    When using this product diuretic effect may occur.

    *Note: This statement can be removed from the label if a diuretic claim is included.

    Health Canada monograph dated 27 March 2026

  • Vaccinium myrtillus L.
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : VITAVEA - Laboratoires Yves Ponroy

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Duo 24 Cheveux Femmes 45+ (VITAVEA - Laboratoires Yves Ponroy): composition and regulation”, https://compoatlas.com/en/supplements/products/7587-duo-24-cheveux-femmes-45, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line